Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2003
10/29/2003EP1009804B1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
10/29/2003EP0996728B1 IMPROVED ANTI-IgE ANTIBODIES AND METHODS OF IMPROVING ANTIBODIES
10/29/2003EP0983272B1 A new class of benzoporphyrin derivative photoactive compounds
10/29/2003EP0745128B1 Hepatitis b virus mutants, reagents and methods for detection
10/29/2003EP0594803B1 Composition for reducing side-effects of a drug
10/29/2003EP0546118B1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
10/29/2003EP0444186B2 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
10/29/2003CN1452661A Viral vectors for use in monitoring HIV drug resistance
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
10/29/2003CN1452634A HLA binding peptides and their uses
10/29/2003CN1452633A Mammalian genes, related reagent and methods
10/29/2003CN1452496A Use of strains of parapox ovis virus against organ fibrosis
10/29/2003CN1452495A Vaccine against microbial pathogens
10/29/2003CN1451437A Staphlococcus aureus preparation and producting method thereof
10/29/2003CN1125877C Hepatitis G. Virus and molecular cloning thereof
10/29/2003CN1125826C Hepatitis E virus gene sequence and its application
10/29/2003CN1125652C Wu Zuze
10/28/2003US6639060 DNA segment encoding a receptor protein related to the erbB proto-oncogene family which previously has not been known; tool for screening for anticancer agents
10/28/2003US6639055 Method for making humanized antibodies
10/28/2003US6638771 Uses an immune reaction to detect soluble liver antigen ("SLA") auto-antibodies
10/28/2003US6638762 Tissue-vectors specific replication and gene expression
10/28/2003US6638750 Diagnosing angiogenesis-related diseases; molecular hybridization, genetic engineering
10/28/2003US6638739 Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
10/28/2003US6638517 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
10/28/2003US6638516 Strain selection of pneumococcal surface proteins
10/28/2003US6638514 Immunogenic attenuated dengue viruses produced by serial passage in primary dog kidney cells
10/28/2003US6638513 Vaccines
10/28/2003US6638511 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
10/28/2003US6638510 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
10/28/2003US6638509 Bound through spacer comprising maleimide-derived polyalkylene glycol and dipeptide; antitumor and anticarcinogenic agents
10/28/2003US6638507 Antigen binding site of antibody; encoded by nucleic acids; diagnostic kits
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003CA2249448C Egg anti-inflammatory composition, method of isolation and use
10/28/2003CA2118010C Antibodies specific for carcinoma-associated antigens
10/28/2003CA2090005C Cross-reactive influenza a immunization
10/23/2003WO2003087841A2 An ephrin-b receptor protein involved in carcinoma
10/23/2003WO2003087840A2 Protein involved in cancer
10/23/2003WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087757A2 Particle-bound human immunodeficiency virus envelope clycoproteins and related compositions and methods
10/23/2003WO2003087408A2 Schizophrenia associated genes
10/23/2003WO2003087389A2 Biologic modulations with nanoparticles
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087378A1 Nucleic acid immunization
10/23/2003WO2003087375A1 Cartilage differentiation regulating gene
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087348A1 Packaging cell line for diphtheria toxin expressing non-replicating adenovirus
10/23/2003WO2003087339A2 Spray freeze dry of compositions for pulmonary administration
10/23/2003WO2003087327A2 Preservation of bioactive materials by freeze dried foam
10/23/2003WO2003087323A2 Biologic modulations with nanoparticles
10/23/2003WO2003087322A2 Production of haematophagous organisms and parasites suitable for vaccine production
10/23/2003WO2003087306A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003WO2003087161A1 Modified factor viii
10/23/2003WO2003087154A2 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments
10/23/2003WO2003087151A1 A sperm polypeptide
10/23/2003WO2003087147A1 Stretptococcal genes involved in osmotic and oxidative stress and in virulence
10/23/2003WO2003087146A2 Purified polypeptides from s. aureus, h. pylori and e. coli involved in cellular transport and metabolism
10/23/2003WO2003087134A2 G-protein coupled receptor ligands and methods
10/23/2003WO2003087131A2 Anti-her2 antibody variants
10/23/2003WO2003087129A2 Immunogenic peptides, and method of identifying same
10/23/2003WO2003087126A2 Heteroclitic analogs and related methods
10/23/2003WO2003087122A2 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments
10/23/2003WO2003087021A2 Nanoparticle delivery systems and methods of use thereof
10/23/2003WO2003086473A1 Mycoplasma polypeptides
10/23/2003WO2003086472A1 Drugs to be used in gene therapy for recessively transmitted genetic disease
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086455A1 Immunoadjuvant
10/23/2003WO2003086454A1 Antigen-loaded chitosan microparticles for oral vaccination
10/23/2003WO2003086453A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
10/23/2003WO2003086450A1 Active antiangiogenic therapy
10/23/2003WO2003086395A1 Tyrosine kinase inhibitors
10/23/2003WO2003086382A1 Tnp-470 polymer conjugates and use thereof
10/23/2003WO2003086315A2 Tyrosine kinase inhibitors
10/23/2003WO2003086311A2 Methods for treating tweak-related conditions
10/23/2003WO2003086308A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003WO2003086296A2 Treatment for type 1 diabetes before and after expression of predisposition markers.
10/23/2003WO2003086289A2 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
10/23/2003WO2003086286A2 Treatment of type 1 diabetes before and after expression of predisposition markers
10/23/2003WO2003086280A2 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003WO2003086277A2 Attenuated gram negative bacteria
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003086097A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003WO2003086041A2 Binding agents and their use in targeting tumor cells
10/23/2003WO2003057714A3 A method of developing an anti-protein and regulation of a cellular function by administering an effective amount of the anti-protein
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003047619A3 Adjuvanted antigenic meningococcal compositions
10/23/2003WO2003040164A3 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/23/2003WO2003039592A3 Cellular vaccines comprising adjuvants
10/23/2003WO2003032917A3 Hookworm vaccine
10/23/2003WO2003031466A3 Angiotensin peptide-carrier conjugates and uses thereof
10/23/2003WO2003020875A3 Staphylococci surface-exposed immunogenic polypeptides
10/23/2003WO2003017755A3 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
10/23/2003WO2003016466A3 ANTI-Aβ ANTIBODIES
10/23/2003WO2003010201A3 Blood group antigen fusion polypeptides and methods of use thereof
10/23/2003WO2003005888A3 Lipophilin complexes for use in cancer diagnosis and therapy
10/23/2003WO2003002602A3 Nogo and nogo receptor derived peptides for t-cell mediated neuroprotection
10/23/2003WO2003000922A3 Chimeric immunomodulatory compounds and methods of using the same
10/23/2003WO2003000883A1 Cell proliferation inhibitors containing anti-glypican 3 antibody
10/23/2003WO2002102312A3 Combination therapy of gamma-interferon and b cell specific antibodies
1 ... 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 ... 1823